Alan COLMAN is research director, at PPL Therapeutics, UK. Professor Colman’s
research focuses on the production of human therapeutic proteins in the milk of
transgenic livestock, and the development of transgenic pigs for organ transplantation
to humans. He has been centrally involved in the development of animal cloning
technology. The company’s objectives—therapeutic proteins and organ
transplantation—are serviced by the development of state of the art technology
that raises several controversial issues including the use and exploitation of animals
for man’s benefit, and the practice, ethics, and potential of other methods of artificial
reproductive technologies. Dr. Colman was professor of biochemistry at the
University of Birmingham, UK, and senior lecturer of biological sciences at the
University of Warwick, UK. Professor Colman received an M.A. from Oxford
University, and a Ph.D. from Cambridge University.